Arno Therapeutics, Inc. (ARNI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 7627.00 | - |
| Gross Profit | - | - | - | - | -7627.00 | - |
| Operating Expenses | - | - | - | - | 13.41 Million | 21.49 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 4.75 Million | 6.65 Million |
| Research and Development Expenses | - | - | - | - | 8.65 Million | 14.84 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 13.41 Million | 21.49 Million |
| Operating Income | - | - | - | - | -13.41 Million | -21.49 Million |
| Interest Expense | - | - | - | - | 28.4 Thousand | 143.00 |
| Income Tax Expense | - | - | - | - | 28.4 Thousand | 143.00 |
| Earnings before Tax | - | - | - | - | -11.5 Million | 7.77 Million |
| Net Income | - | - | - | - | -11.53 Million | 7.77 Million |
| Earnings Per Share Basic | - | - | - | - | -0.57 | 0.38 |
| Earnings Per Share Diluted | - | - | - | - | -0.57 | 0.31 |
| Weighted Average Shares Outstanding | - | - | - | - | 20.4 Million | 20.38 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 20.4 Million | 24.8 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -13.39 Million | -21.43 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2016 Q3 | 2016 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | 2.23 Million | 3.31 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 1.11 Million | 1.25 Million |
| Research and Development Expenses | - | - | - | - | 1.11 Million | 2.05 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 2.23 Million | 3.31 Million |
| Operating Income | - | - | - | - | -2.23 Million | -3.31 Million |
| Interest Expense | - | - | - | - | 214.00 | 250.00 |
| Income Tax Expense | - | - | - | - | 214.00 | 250.00 |
| Earnings before Tax | - | - | - | - | -3.84 Million | -2.14 Million |
| Net Income | - | - | - | - | -3.84 Million | -2.14 Million |
| Earnings Per Share Basic | - | - | - | - | -0.09 | -0.05 |
| Earnings Per Share Diluted | - | - | - | - | -0.09 | -0.05 |
| Weighted Average Shares Outstanding | - | - | - | - | 44.7 Million | 41.56 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 44.7 Million | 41.56 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | -2.22 Million | -3.3 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
600600
TCID
SAKL
6138
3123
601968